Compare
Globus Medical Inc vs West Pharmaceutical Services Inc vs MiniMed Group, Inc. vs Teleflex Inc
| Latest fiscal year | Globus Medical Inc GMED | West Pharmaceutical Services Inc WST | MiniMed Group, Inc. MMED | Teleflex Inc TFX |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-04-24 | 2025-12-31 |
| Revenue | $2.94B | $3.07B | $3.10B | $1.99B |
| Revenue growth (YoY) | +16.7% | +6.3% | +14.3% | +17.2% |
| Gross margin | 67.4% (computed) | 35.9% | 54.2% | 56.2% |
| Operating margin | 16.3% | 19.0% | -6.1% | 5.9% |
| Net margin | 18.3% | 16.1% | -10.7% | -45.4% |
| Net income | $537.87M | $493.70M | -$333.00M | -$905.64M |
| EPS (Diluted) | $3.92 | $6.79 | -$1.30 | -$20.25 |
| Operating cash flow | $753.45M | $754.80M | -$197.00M | $96.68M |
| Free cash flow | $588.77M | $468.90M | -$420.00M | $1.45M |
| Cash & equivalents | $526.16M | $791.30M | $298.00M | $378.56M |
| Total assets | $5.30B | $4.27B | $4.63B | $6.95B |
| Total liabilities | $729.51M | $1.09B | $1.02B | $3.82B |
| Shareholders' equity | $4.57B | $3.18B | $3.61B | $3.12B |
| Return on year-end equity | 11.8% | 15.5% | -9.2% | -29.0% |
| Shares outstanding | n/a | 72.00M | 280.82M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Globus Medical Inc | West Pharmaceutical Services Inc | MiniMed Group, Inc. | Teleflex Inc |
|---|---|---|---|---|
| Latest | $2.94B Ended 2025-12-31 | $3.07B Ended 2025-12-31 | $3.10B Ended 2026-04-24 | $1.99B Ended 2025-12-31 |
| 1 year earlier | $2.52B Ended 2024-12-31 | $2.89B Ended 2024-12-31 | $2.71B Ended 2025-04-25 | $1.70B Ended 2024-12-31 |
| 2 years earlier | $1.57B Ended 2023-12-31 | $2.95B Ended 2023-12-31 | $2.47B Ended 2024-04-26 | $1.71B Ended 2023-12-31 |
| 3 years earlier | $1.02B Ended 2022-12-31 | $2.89B Ended 2022-12-31 | n/a | $2.79B Ended 2022-12-31 |
| 4 years earlier | $958.10M Ended 2021-12-31 | $2.83B Ended 2021-12-31 | n/a | $2.81B Ended 2021-12-31 |